CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $88,397 | $53,798 | $72,359 | $85,361 |
| - Cash | $7,571 | $6,777 | $8,371 | $11,980 |
| + Debt | $495 | $507 | $389 | $707 |
| Enterprise Value | $81,321 | $47,528 | $64,377 | $74,088 |
| Revenue | $1,830 | $14,591 | $16,277 | $7,585 |
| % Growth | -87.5% | -10.4% | 114.6% | – |
| Gross Profit | $1,201 | $9,950 | $11,649 | $18,678 |
| % Margin | 65.6% | 68.2% | 71.6% | 246.3% |
| EBITDA | $3,481 | $2,498 | $4,525 | $1,789 |
| % Margin | 190.2% | 17.1% | 27.8% | 23.6% |
| Net Income | $351 | $1,586 | $3,019 | $1,379 |
| % Margin | 19.2% | 10.9% | 18.5% | 18.2% |
| EPS Diluted | 0.12 | 0.48 | 1.08 | 1.44 |
| % Growth | -75% | -55.6% | -25% | – |
| Operating Cash Flow | $456 | $3,308 | $1,425 | $3,145 |
| Capital Expenditures | -$166 | $649 | -$649 | -$890 |
| Free Cash Flow | $290 | -$776 | $776 | $1,957 |